These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 2416264)
21. [Treatment of multiple sclerosis. The present and the future. Study Group on Diagnosis and Therapy of Multiple Sclerosis]. Cazzato G; Antonello RM; Zorzon M; Torre P; Zivadinov R; Moretti R; Bragadin LM; De Masi R; Nasuelli D Recenti Prog Med; 1999 Oct; 90(10):538-44. PubMed ID: 10592740 [TBL] [Abstract][Full Text] [Related]
22. Multiple sclerosis in childhood: understanding and caring for children with an "adult" disease. Boyd JR; MacMillan LJ Axone; 2000 Dec; 22(2):15-21. PubMed ID: 11901486 [TBL] [Abstract][Full Text] [Related]
25. [Interferons in neurology]. Fernández O Neurologia; 1995 Jan; 10(1):26-35. PubMed ID: 7534467 [No Abstract] [Full Text] [Related]
26. Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon-beta. McDonald WI; Miller DH; Thompson AJ Ann Neurol; 1994 Jul; 36(1):14-8. PubMed ID: 8024255 [No Abstract] [Full Text] [Related]
27. Expanded clinical trials of treatments for multiple sclerosis. The Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis of The National Multiple Sclerosis Society. Whitaker JN Ann Neurol; 1993 Dec; 34(6):755-6. PubMed ID: 8250523 [No Abstract] [Full Text] [Related]
28. [Hypothyroidism-induced by cytokine therapy]. Sato K Nihon Rinsho; 2006 May; Suppl 1():524-8. PubMed ID: 16776206 [No Abstract] [Full Text] [Related]
30. Medications used in the treatment of multiple sclerosis. Schapiro RT Phys Med Rehabil Clin N Am; 1999 May; 10(2):437-46, ix. PubMed ID: 10370939 [TBL] [Abstract][Full Text] [Related]
31. [Guidelines for drug treatment of multiple sclerosis]. Kollegger H; Vass K; Marschall I; Koch G; Deecke L Wien Klin Wochenschr; 1993; 105(16):443-52. PubMed ID: 7692677 [TBL] [Abstract][Full Text] [Related]
32. Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient. Heinzerling L; Dummer R; Burg G; Schmid-Grendelmeier P Eur J Dermatol; 2002; 12(2):194-7. PubMed ID: 11872423 [TBL] [Abstract][Full Text] [Related]
33. Treatment of multiple sclerosis with various interferons: the cons. Johnson KP Neurology; 1988 Jul; 38(7 Suppl 2):62-5. PubMed ID: 3133576 [TBL] [Abstract][Full Text] [Related]
34. Interferon. Hood LE Am J Nurs; 1987 Apr; 87(4):459-65. PubMed ID: 2436479 [No Abstract] [Full Text] [Related]
35. Immortal time bias in the study of effectiveness of interferon-beta in multiple sclerosis. Renoux C; Suissa S Ann Neurol; 2008 Jul; 64(1):109-10; author reply 110. PubMed ID: 18668635 [No Abstract] [Full Text] [Related]
36. Interferon, an antiviral drug for use in man. Myers M; Galasso G Tex Rep Biol Med; 1981-1982; 41():543-8. PubMed ID: 6189221 [No Abstract] [Full Text] [Related]
37. [10 years of interferon treatment in multiple sclerosis. Does the future belong to high-dose therapy?]. MMW Fortschr Med; 2003 May; 145 Suppl 2():108. PubMed ID: 14579501 [No Abstract] [Full Text] [Related]
38. [Current concepts on the use of some immunomodulatory drugs in the treatment of multiple sclerosis]. Correale J; Cristiano E Medicina (B Aires); 2001; 61(4):470-80. PubMed ID: 11563177 [TBL] [Abstract][Full Text] [Related]
39. Current evidence and therapeutic strategies for multiple sclerosis. Wingerchuk DM Semin Neurol; 2008 Feb; 28(1):56-68. PubMed ID: 18256987 [TBL] [Abstract][Full Text] [Related]
40. Drug therapy in multiple sclerosis. Eadie M Aust Fam Physician; 1987 Jul; 16(7):1020, 1022. PubMed ID: 2444201 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]